Rekart Michael L, Patrick David M, Chakraborty Bubli, Maginley Juanita J L, Jones H D, Bajdik Chris D, Pourbohloul Babak, Brunham Robert C
University of British Columbia Centre for Disease Control, Canada.
Lancet. 2003 Jan 25;361(9354):313-4. doi: 10.1016/s0140-6736(03)12335-5.
From mid 1997 to end of 1999, there was a sexually-transmitted infectious syphilis outbreak mainly in heterosexual people in British Columbia, Canada, that was concentrated in Vancouver. The rate across the province increased from less than 0.5 to 3.4 per 100000, and the rate in Vancouver reached 12.9 per 100000. We aimed to eliminate the syphillis outbreak by treating people at risk of infection. In 2000, a targeted mass treatment programme provided azithromycin (1.8 g orally) to 4384 at-risk residents in this city. After the programme, syphilis frequency fell significantly for 6 months (p=0.016), but rose again in 2001. Results from curve fitting analyses showed that the number of cases in 2001 (177) was higher than expected (0.0001<p<0.0044). This rate rebound and the absence of a sustained effect suggest that targeted mass treatment for syphilis, even though feasible, should not be done routinely.
从1997年年中到1999年底,加拿大不列颠哥伦比亚省主要在异性恋人群中出现了性传播感染梅毒的疫情,疫情集中在温哥华。全省发病率从每10万人不到0.5例增至3.4例,温哥华的发病率达到每10万人12.9例。我们旨在通过治疗有感染风险的人群来消除梅毒疫情。2000年,一项有针对性的大规模治疗计划为该市4384名有感染风险的居民提供了阿奇霉素(口服1.8克)。该计划实施后,梅毒发病率在6个月内显著下降(p=0.016),但在2001年又再次上升。曲线拟合分析结果显示,2001年的病例数(177例)高于预期(0.0001<p<0.0044)。这种发病率反弹以及缺乏持续效果表明,即使可行,梅毒的有针对性大规模治疗也不应常规进行。